The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design?

Author： McCluskey A.   Ackland1 S.P.   Gardiner E.   Walkom C.C.   Sakoff1 J.A.  

Publisher： Cognizant Communication Corporation

ISSN： 1460-2148

Source： Anti-Cancer Drug Design, Vol.16, Iss.6, 2001-12, pp. : 291-303

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rational Drug Design of G-Quartet DNA as Anti-Cancer Agents

By  

Current Pharmaceutical Design, Vol. 11, Iss. 22, 2005-08 ,pp. : 2841-2854

Bentham Science Publishers

Access to resources Recommend Favorite

G-quadruplex DNA: a potential target for anti-cancer drug design

By Han H.   Hurley L.H.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 4, 2000-04 ,pp. : 136-142

Elsevier

Access to resources Recommend Favorite

Leptin and the Ob-Receptor as Anti-Obesity Target: Recent In Silico Advances in the Comprehension of the Protein-Protein Interaction and Rational Drug Design of Anti- Obesity Lead Compounds

By  

Current Pharmaceutical Design, Vol. 20, Iss. 1, 2014-01 ,pp. : 136-145

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Protein Tyrosine Phosphatases for Anticancer Drug Discovery

By  

Current Pharmaceutical Design, Vol. 16, Iss. 16, 2010-06 ,pp. : 1843-1862

Bentham Science Publishers

Access to resources Recommend Favorite

Insights from Pim1 structure for anti-cancer drug design

By Ogawa Naoko   Yuki Hitomi   Tanaka Akiko  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 12, 2012-12 ,pp. : 1177-1192

Informa Healthcare

Access to resources Recommend Favorite